Preliminary clinical experience indicates that tranylcypromine (Parnate) is an improved type of monoamine oxidase inhibitor that appears to be more rapid in its action, effective in smaller doses (1 to 3 tablets a day–usually one tablet b. i. d.) and relatively free of side effects. It is indicated for treatment of any type of depression and sometimes for withdrawn schizophrenic patients.
Abstract Teaser